Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Quorum sensing regulating the heterogeneous transformation of antibiotic resistance genes in microplastic biofilms
Liu, Xiaowei; Huang, Chuang; Yu, Hongxia; Yang, Yaning; Ma, Lulu; Zhao, Bin; Zhong, Tianyang; Zhang, Lilan; Peng, Weihua; Gong, Wenwen; Ding, Yan Share Save Share Save Share Save Share Save Share Save Mutational landscape of SWI/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patientsXu, H.; Chen, H. -c.; Yang, L.; Yang, G.; Liang, L.; Yang, Y.; Tang, H.; Bao, H.; Wu, X.; Shao, Y.; An, G.; Wang, Y. Share Save Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)Yang, Guangjian; Xu, Haiyan; Yang, Yaning; Zhang, Shuyang; Xu, Fei; Hao, Xuezhi; Li, Junling; Xing, Puyuan; Hu, Xingsheng; Liu, Yutao; Wang, Lin; Lin, Lin; Wang, Zhijie; Duan, Jianchun; Wang, Jie; Wang, Yan Share Save Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer (vol 20, 187, 2022)Liu, Chengming; Yang, Lu; Xu, Haiyan; Zheng, Sufei; Wang, Zhanyu; Wang, Sihui; Yang, Yaning; Zhang, Shuyang; Feng, Xiaoli; Sun, Nan; Wang, Yan; He, Jie Share Save Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancerLiu, Chengming; Yang, Lu; Xu, Haiyan; Zheng, Sufei; Wang, Zhanyu; Wang, Sihui; Yang, Yaning; Zhang, Shuyang; Feng, Xiaoli; Sun, Nan; Wang, Yan; He, Jie Share Save First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2-altered NSCLC: a retrospective real-world POLISH studyYang, Guangjian; Yang, Yaning; Liu, Runze; Li, Weihua; Xu, Haiyan; Hao, Xuezhi; Li, Junling; Xing, Puyuan; Zhang, Shuyang; Ai, Xin; Xu, Fei; Wang, Yan Share Save The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase InhibitorsYang, Guangjian; Liu, Chengming; Hu, Jiaqi; Sun, Yang; Hu, Peizeng; Liu, Liu; Xu, Haiyan; Li, Dazhou; Li, Weihua; Yang, Yaning; Sun, Nan; He, Jie; Wang, Yan Share Save Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL)Yang, Guangjian; Hao, Xuezhi; Hu, Jiaqi; Dong, Keke; Xu, Haiyan; Yang, Lu; Zhang, Shuyang; Yang, Yaning; Xu, Fei; Li, Junling; Wang, Yan Share Save Share Save Share Save Risk-Adapted Survival Benefit of Intensity-Modulated Radiation Therapy in Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter StudyWu, T.; Yang, Y.; Zhu, S. Y.; Shi, M.; Su, H.; Wang, Y.; He, X.; Li-ming, X.; Yuan, Z. Y.; Zhang, L. L.; Wu, G.; Qu, B.; Qian, L. T.; Xiaorong, H.; Zhang, Y.; Zhu, Y.; Cao, J.; Lan, S. M.; Wu, J. X.; Qi, S.; Chen, B.; Li, Y. X. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
